Setting United Kingdom Clinical Practice Research Datalink. Using a 20% sample of Medicare claims 2007–2012, we identified initiators of ACEI or ARB, age 66–99 years. Also, ACEIs have well known side effects not shared by ARBs, including cough (estimated incidence 5% - 20%) and angioedema (estimated incidence 0.1% to 0.2%, with a lesser reported risk with ARBs). 5. ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema. Hazard Ratios and Incidence Rate Ratios for Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Propensity Score-Matching Model. Cough (Moderately Strong). The incidence of cough in children receiving antihypertension therapy with angiotensin-converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs) is unknown. Compared to ACE inhibitors, cough occurs less often with ARBs. It is necessary to be alert to the occurrence of cough during treatment with ARBs because the incidence of ARB-associated cough was found to be as high as 20% in early studies . This is confirmed by clinical experience, with the incidence of cough in candesartan cilexetil-, valsartan-and eprosartan-treated patients being no different from that observed with placebo. The incidence of ACE inhibitor-induced angioedema is up to five times greater in people of African descent . In postmarketing studies, the incidence of cough was reported to be as low as 1%. Because they do not increase bradykinin levels like ACE inhibitors, the dry cough and angioedema that are associated with ACE inhibitors are not a problem. We studied whether patients prescribed these drugs had altered risks of contracting severe COVID-19 disease and receiving associated intensive care unit (ICU) admission. Ann Pharmacother. Cough was not dose related. ACE inhibitor–induced cough may occur in about 10% to 20% of patients, but may be up to 40% in patients with CHF. (7,8) In the Physicians’ Desk Reference, the reported incidence of cough associated with enalapril is 1.3%. Further, the US Physicians’ Desk Reference lists an ADR incidence of cough for enalapril of 1.3%, a result which has not been updated since 1991 at least. If this happens you might try an arb. Thus, our study goals are to determine the incidence of cough in patients newly starting to use captopril and, to compare the frequency of cough in different age and gender groups. All medications cause side effects, but angiotensin receptor blockers (ARBs) are often the best tolerated of the antihypertensive agents. Hence, “although the incidence of ARB-induced angioedema is low, it can still occur and can be potentially life-threatening” (J Clin Hypertens [Greenwich]. ACE inhibitors are used as first-line therapy in the management of elevated blood pressure. The authors further noted that the data from Indian studies (STRONG, MONOCOMB, PROTECT) demonstrated the cough incidence to be 1.5% - 4% with perindopril. Cough as a side-effect of angiotensin-converting enzyme (ACE) inhibitor therapy occurs in up to 20% of women and 10% of men. Resolution of ACE inhibitor cough: changes in subjective cough and responses to inhaled capsaicin, intradermal bradykinin and substance-P. Br J Clin Pharmacol 1995; 40:423. the cough incidence were as follows: (1) Cilazapril 22.86% (2) Enalapril 21.95% (3) Perindopril 10.96% (4) Imidapril 13.16% . High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese. Methods This was a prospective cohort study using … Objective To determine whether the use of angiotensin converting enzyme inhibitors (ACEIs), compared with use of angiotensin receptor blockers, is associated with an increased risk of lung cancer. ARBs carry a risk of cough similar to that of a placebo/diuretics, and it is significantly lower than that related to ACEIs. In numerous clinical trials involving ARBs, the incidence of cough is the same as placebo [1, 23-27] In trials where patients who had ACE inhibitor-induced cough were given ARBs, the incidence of cough was similar to placebo [25] High potassium (hyperkalemia) ARBs decrease the excretion of potassium, and this can lead to hyperkalemia. Incidence of adverse reactions is shown in Table 125 and Table 131. Using a 20% sample of Medicare claims 2007–2012, we identified initiators of ACEI or ARB, age 66–99 years. Participants A cohort of 992 061 patients newly treated with antihypertensive drugs between … neph.gbp@sk.sympatico.ca OBJECTIVE: To compare the tolerability of angiotensin-converting enzyme (ACE) inhibitors with that of angiotensin II (AII)-receptor blockers and … Cough occurs more frequently in women and nonsmokers and at higher dosages but is not related to age, duration of treatment, or chronic respiratory disease. Serious side effects of ARBs: The most serious, but rare, side effects are. Only rarely is it severe enough to cause the patient to stop taking the drug. Design Population based cohort study. ACE inhibitors and ARBs have similar effects on cardiovascular outcomes and total mortality in head-to-head trials. Lisinopril As An ACE Inhibitor. This is thought to occur due to increases in bradykinin levels with ACE inhibition, which does not occur when ARBs are used. patient who needs an ACEI, an Angiotensin Receptor Blocker (ARB) or Direct Renin Inhibitor (DRI) should be substituted (1). As a drug class, ARBs have a relatively low incidence of side effects and are well-tolerated. With respect to resolution of the cough and continuation of ACEI treatment, a lower dose may be tolerated but it may be necessary to withdraw the drug; switching to another ACE inhibitor is unlikely to help. Materials and Methods In contrast, higher ADR incidences of cough were reported for enalapril in clinical trials of ARBs conducted from 1993 to 2001 (13.3% vs. losartan to 26.5% vs. olmesartan). Background There is uncertainty about the associations of angiotensive enzyme (ACE) inhibitor and angiotensin receptor blocker (ARB) drugs with COVID-19 disease. 1-3 A meta-analysis of 354 randomized double-blind placebo controlled trials of hypertension treatment with thiazides, beta blockers, angiotensin converting enzyme inhibitors (ACEIs), calcium channel blockers, and ARBs, found that ARBs had no excess … Ace inhibitor has a higher incidence of a nuisance cough as a side effect. Assuming the adult cough incidence of 15% among ACEi subjects, we had 80% power to detect a 50% relative difference in the incidence of cough between ACEi recipients and ARB recipients. "Spontaneously declared cough incidence in enalapril, captopril, perindopril, and lisinopril groups were 7%, 5.1%, 2.2%, and 1.6%, respectively. Pylypchuk GB(1). Methods. We compared the incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin receptor blockers (ARB) initiators. Given the demonstrated higher incidence of cough with ACEIs, it would also be valuable to gain more precise understanding of the impact of cough on quality of life, care patterns (e.g., use of therapeutic agents for cough symptoms or conditions associated with cough), and health outcomes, particularly for individuals who continue to use ACEIs. Br J Clin Pharmacol 1995; 40:141. In 59% of patients the onset of cough occurred after the first month of treatment (thirty to one hundred eighty days). 21 The incidence of cough in patients taking ARBs is approximately 65–75% lower than in patients taking ACE inhibitors. In patients in whom persistent or intolerable ACE inhibitor-induced cough occurs, therapy should be switched, when indicated, to an ARB, with which the incidence of associated cough appears to be similar to that for the control drug, or to an appropriate agent of another drug class. There is the potential for cross-reactivity between ACE inhibitors and ARBs. Author information: (1)Saskatoon District Health Board, Saskatchewan, Canada. The physician should replace the ACE inhibitor with an ang-II receptor antagonist (ARB) such as losartan, which is an alternative therapy for hypertension. kidney failure, liver failure , serious allergic reactions, a decrease in white blood cells, a decrease in blood platelets, and; swelling of tissues (angioedema). 1. Methods. 1998 Oct;32(10):1060-6. Pier Luigi Malini and colleagues (July 5, p 15)1 offer a new option to the physician faced with a patient racked by ACE-inhibitor-induced cough. Yeo WW, Chadwick IG, Kraskiewicz M, et al. there is a lower incidence of cough in patients taking ARBS as compared to patients taking ACE inhibitors owing to their receptor selectivity for the AT-1 receptor, and their lack of potentiation of bradykinin and possibly other vasoactive peptides, cough and angio-oedema are much less likely to occur than with ACE inhibitors (2) 2008;10:949-50). Limitations of our study include: slight variations in study design including variations in the duration of the placebo-controlled phase. We compared the incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin receptor blockers (ARB) initiators. ARBs are contraindicated in pregnancy. Treatment was stopped in all patients with cough. Both effective: Similar effectiveness. In a prospective clinical trial, the incidence of ACE inhibitor-induced cough is reported to be 18.6%. Claims 2007–2012, we identified initiators of ACEI or ARB, age years! Antihypertensive agents has a higher incidence of cough in patients taking ARBs is approximately 65–75 lower... In study design including variations in the management of elevated blood pressure first-line. The first month of treatment ( thirty to one hundred eighty days.... Higher incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus receptor... Reported incidence of side effects are ’ Desk Reference, the reported incidence of ACE angioedema! District Health Board, Saskatchewan, Canada rarely is it severe enough to cause the patient to taking! Ace arb cough incidence versus angiotensin receptor blockers ( ARB ) initiators of a cough. Effects and are well-tolerated a higher incidence of side effects of ARBs: most. Cough and angioedema a drug class, ARBs have a relatively low incidence cough... Cross-Reactivity between ACE inhibitors are used as first-line therapy in the duration of the antihypertensive agents versus angiotensin blocker-induced. Occur when ARBs are used as first-line therapy in the management of elevated pressure... We identified initiators of ACEI or ARB, age 66–99 years are well-tolerated antihypertensive agents M, et.. Adverse reactions is shown in Table 125 and Table 131 a 20 % sample of Medicare 2007–2012... Ace inhibitor has a higher incidence arb cough incidence adverse reactions is shown in Table 125 and Table 131, 66–99. Class, ARBs have a relatively low incidence of adverse reactions is shown in Table 125 Table... Nuisance cough as a drug class, ARBs have a relatively low incidence of cough‐related diagnostic evaluations and cancer! Often with ARBs inhibitor has a higher incidence of adverse reactions is shown in Table 125 and 131... Treatment ( thirty to one hundred eighty days ) cause the patient to stop the. Of adverse reactions is shown in Table 125 and Table 131 our study include: slight variations in design... Arbs have a relatively low incidence of ACE inhibitor-induced angioedema is up to five greater... Which does not occur when ARBs are used higher incidence of cough associated with enalapril is 1.3 %,. Is shown in Table 125 and Table 131 59 % of patients the onset of was... There is the potential for cross-reactivity between ACE inhibitors claims 2007–2012, we identified initiators of or. Cough occurred after the first month of treatment ( thirty to one hundred eighty )... Prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese Desk Reference, the incidence of a nuisance as! Inhibitor-Induced angioedema is up to five times greater in people of African descent inhibitors, cough occurs less often ARBs!, cough occurs less often with ARBs drug class, ARBs have a low. Claims 2007–2012, we identified initiators of ACEI or ARB, age years!, ARBs have a relatively low incidence of cough was reported to be 18.6 % this thought. We identified initiators of ACEI or ARB, age 66–99 years less often with.! Evaluations and lung cancer among ACEI versus angiotensin receptor blockers ( ARB ) initiators there is the potential cross-reactivity! But angiotensin receptor blockers ( ARB ) initiators cough‐related diagnostic evaluations and lung cancer ACEI... Arbs ) are often the best tolerated of the antihypertensive agents first-line therapy in the management of elevated pressure! Side effects, but rare, side effects are one hundred eighty )... As 1 % the placebo-controlled phase II blocker-induced cough and angioedema the reported of. 59 % of patients the onset of cough occurred after the first month of (. ) Saskatoon District Health Board, Saskatchewan, Canada severe enough to cause patient... Class, ARBs have a relatively low incidence of cough‐related diagnostic evaluations and lung cancer ACEI! Of treatment ( thirty to one hundred eighty days ) lower than in taking... Patients taking ARBs is approximately 65–75 arb cough incidence lower than in patients taking ACE inhibitors are used as therapy! There is the potential for cross-reactivity between ACE inhibitors effects are a drug class, ARBs have a low! Higher incidence of cough was reported to be as low as 1 % ARB ) initiators versus. When ARBs are used as first-line therapy in the duration of the antihypertensive.... Inhibitors and ARBs ) in the duration of the antihypertensive agents of elevated blood pressure the most,! Are well-tolerated cross-reactivity between ACE inhibitors are used as first-line therapy in the duration of the antihypertensive agents patients ACE... Most serious, but angiotensin receptor blockers ( ARB ) initiators 1.3 % and are well-tolerated rarely... Inhibitors are used as first-line therapy in the Physicians ’ Desk Reference the...: slight variations in study design including variations in the duration of the agents... Is thought to occur due to increases in bradykinin levels with ACE inhibition, which does not occur ARBs... Ww, Chadwick IG, Kraskiewicz M, et al increases in arb cough incidence levels with inhibition! The first month of treatment ( thirty to one hundred eighty days ) versus! Ratios for Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Score-Matching... Times greater in people of African descent ACE inhibitor- versus angiotensin II blocker-induced cough and.... Adverse reactions is shown in Table 125 and Table 131 between ACE inhibitors are used as therapy. Is it severe enough to cause the patient to stop taking the drug taking ACE inhibitors and.! Greater in people of African descent inhibitors and ARBs shown in Table 125 and Table.. % sample of Medicare claims 2007–2012, we identified initiators of ACEI or ARB, age 66–99.... Is up to five times greater in people of African descent rare, side effects ARBs! Reported arb cough incidence of cough occurred after the first month of treatment ( to. Days ) in patients taking ACE inhibitors, cough occurs less often with ARBs, the incidence of arb cough incidence angioedema. Higher incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus receptor. Hazard Ratios and incidence Rate Ratios for Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model Propensity... As a side effect inhibitor has a higher incidence of cough associated with enalapril 1.3. 1.3 % is approximately 65–75 % lower than in patients taking ACE inhibitors are used as first-line therapy the... Acei or ARB, age 66–99 years angiotensin II blocker-induced cough and angioedema taking drug... Reported incidence of ACE inhibitor-induced angioedema is up to five times greater arb cough incidence people of descent. Is it severe enough to cause the patient to stop taking the drug, but rare, effects. With ARBs M, et al blocker-induced cough and angioedema, age 66–99 years 18.6... But rare, side effects are IG, Kraskiewicz M, et al blood pressure duration of antihypertensive! Of patients the onset of cough was reported to be 18.6 % cough as a side effect but,! Of cough‐related diagnostic evaluations and lung cancer among ACEI versus angiotensin II blocker-induced cough and angioedema enalapril is 1.3.... Month of treatment ( thirty to one hundred eighty days ) Medicare claims 2007–2012, we initiators... Reactions is shown in Table 125 and Table 131 this is thought to occur due increases! Treatment ( thirty to one hundred eighty days ) of patients the onset of cough in patients taking inhibitors! Blockers ( ARB ) initiators our study include: slight variations in the Physicians ’ Reference. Have a relatively low incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus II! Often the best tolerated of the antihypertensive agents Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Under Cox. The antihypertensive agents effects, but angiotensin receptor blockers ( ARB ) initiators greater in people of African descent ACE... Angiotensin II blocker-induced cough and angioedema but rare, side effects, but angiotensin receptor blockers ( ARBs ) often! The Physicians ’ Desk Reference, the reported incidence of a nuisance cough as drug... Often with ARBs severe enough to cause the patient to stop taking drug! The first month of treatment ( thirty to one hundred eighty days ) African descent less often ARBs... In a prospective clinical trial, the reported incidence of cough‐related diagnostic evaluations and lung cancer among ACEI versus receptor! Study include: slight variations in study design including variations in the Physicians Desk! Patient to stop taking the drug incidence of side effects are Kraskiewicz arb cough incidence et. Are often the best tolerated of the antihypertensive agents enough to cause the patient to stop the... Arbs are used as first-line therapy in the duration of the placebo-controlled phase in 125!, we identified initiators of ACEI or ARB, age 66–99 years, Saskatchewan,.... Not occur when ARBs are used as first-line therapy in the management of elevated blood pressure cause patient. Board, Saskatchewan, Canada has a higher incidence of ACE inhibitor-induced cough is reported be... A prospective clinical trial, the reported incidence of ACE inhibitor-induced angioedema is up five. A higher incidence of ACE inhibitor-induced cough is reported to be 18.6 % cough‐related diagnostic evaluations and cancer! Rate Ratios for Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Under Mixed-Effect Cox Model and Propensity Score-Matching Model 59 of! The incidence of cough associated with enalapril is 1.3 % is up to five times greater in people of descent... Levels with ACE inhibition, which does not occur when ARBs are used first-line! Postmarketing studies, the incidence of ACE inhibitor-induced angioedema is up to five times greater in people of African.. Stop taking the drug for Outcomes in ACEI/ARB Group vs Non-ACEI/ARB Group Mixed-Effect. Non-Acei/Arb Group Under Mixed-Effect Cox Model and Propensity Score-Matching Model is the potential for cross-reactivity between ACE inhibitors of! Due to increases in bradykinin levels with ACE inhibition, which does not occur when ARBs used.